262
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Serum Proteomic Signatures in Umbilical Cord Blood of Preterm Neonates Delivered by Women with Gestational Diabetes

, , , , , , , ORCID Icon & show all
Pages 1525-1539 | Received 29 Jan 2023, Accepted 19 May 2023, Published online: 26 May 2023

References

  • Bartaskova D. Diabetes in pregnancy: current ways of treatment. Vnitr Lek. 2019;65(4):256–263. doi:10.36290/vnl.2019.044
  • Peng S, Zhang J, Liu L, et al. Newborn meconium and urinary metabolome response to maternal gestational diabetes mellitus: a preliminary case-control study. J Proteome Res. 2015;14(4):1799–1809. doi:10.1021/pr5011857
  • Wang C, Wei Y, Zhang X, et al. A randomized clinical trial of exercise during pregnancy to prevent gestational diabetes mellitus and improve pregnancy outcome in overweight and obese pregnant women. Am J Obstet Gynecol. 2017;216(4):340–351. doi:10.1016/j.ajog.2017.01.037
  • Nguyen CL, Pham NM, Binns CW, Duong DV, Lee AH. Prevalence of gestational diabetes mellitus in eastern and Southeastern Asia: a systematic review and meta-analysis. J Diabetes Res. 2018;2018:6536974. doi:10.1155/2018/6536974
  • Juan J, Yang H. Prevalence, prevention, and lifestyle intervention of gestational diabetes mellitus in China. Int J Environ Res Public Health. 2020;17(24):9517. doi:10.3390/ijerph17249517
  • Gao L, Chen CR, Wang F, et al. Relationship between age of pregnant women with gestational diabetes mellitus and mode of delivery and neonatal Apgar score. World J Diabetes. 2022;13(9):776–785. doi:10.4239/wjd.v13.i9.776
  • Kong L, Nilsson IAK, Gissler M, Lavebratt C. Associations of maternal diabetes and body mass index with offspring birth weight and prematurity. JAMA Pediatr. 2019;173(4):371–378. doi:10.1001/jamapediatrics.2018.5541
  • Tse BC, Block B, Figueroa H, Yao R. Adverse neonatal outcomes associated with pregestational diabetes mellitus in infants born preterm. Am J Obstetr Gynecol MFM. 2020;2(4):100213. doi:10.1016/j.ajogmf.2020.100213
  • Billionnet C, Mitanchez D, Weill A, et al. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia. 2017;60(4):636–644. doi:10.1007/s00125-017-4206-6
  • Meng X, Zhu B, Liu Y, et al. Unique biomarker characteristics in gestational diabetes mellitus identified by LC-MS-based metabolic profiling. J Diabetes Res. 2021;2021:6689414. doi:10.1155/2021/6689414
  • Zhou Y, Zhao R, Lyu Y, et al. Serum and amniotic fluid metabolic profile changes in response to gestational diabetes mellitus and the association with maternal-fetal outcomes. Nutrients. 2021;13(10):3644. doi:10.3390/nu13103644
  • Liu X, Sun J, Wen X, et al. Proteome profiling of gestational diabetes mellitus at 16–18 weeks revealed by LC-MS/MS. J Clin Lab Anal. 2020;34(9):e23424. doi:10.1002/jcla.23424
  • Suff N, Story L, Shennan A. The prediction of preterm delivery: what is new? Semin Fetal Neonatal Med. 2019;24(1):27–32. doi:10.1016/j.siny.2018.09.006
  • Frey HA, Klebanoff MA. The epidemiology, etiology, and costs of preterm birth. Semin Fetal Neonatal Med. 2016;21(2):68–73. doi:10.1016/j.siny.2015.12.011
  • Galindo-Sevilla N, Reyes-Arroyo F, Mancilla-Ramirez J. The role of complement in preterm birth and prematurity. J Perinat Med. 2019;47(8):793–803. doi:10.1515/jpm-2019-0175
  • Liu K, Chen Y, Tong J, Yin A, Wu L, Niu J. Association of maternal obesity with preterm birth phenotype and mediation effects of gestational diabetes mellitus and preeclampsia: a prospective cohort study. BMC Pregnancy Childbirth. 2022;22(1):459. doi:10.1186/s12884-022-04780-2
  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med. 1998;15(7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
  • Soonthornvacharin S, Rodriguez-Frandsen A, Zhou Y, et al. Systems-based analysis of RIG-I-dependent signalling identifies KHSRP as an inhibitor of RIG-I receptor activation. Nature Microbiol. 2017;2:17022. doi:10.1038/nmicrobiol.2017.22
  • Fang Y, Wang P, Xia L, et al. Aberrantly hydroxymethylated differentially expressed genes and the associated protein pathways in osteoarthritis. PeerJ. 2019;7:e6425. doi:10.7717/peerj.6425
  • Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28(1):27–30. doi:10.1093/nar/28.1.27
  • Kuperman AA, Kenet G, Papadakis E, Brenner B. Intraventricular hemorrhage in preterm infants: coagulation perspectives. Semin Thromb Hemost. 2011;37(7):730–736. doi:10.1055/s-0031-1297163
  • Kuperman AA, Brenner B, Kenet G. Intraventricular hemorrhage in preterm infants and coagulation--ambivalent perspectives? Thromb Res. 2013;131(Suppl 1):S35–S38. doi:10.1016/S0049-3848(13)70018-5
  • Neary E, Okafor I, Al-Awaysheh F, et al. Laboratory coagulation parameters in extremely premature infants born earlier than 27 gestational weeks upon admission to a neonatal intensive care unit. Neonatology. 2013;104(3):222–227. doi:10.1159/000353366
  • Salonvaara M, Riikonen P, Kekomaki R, et al. Effects of gestational age and prenatal and perinatal events on the coagulation status in premature infants. Arch Dis Child. 2003;88(4):F319–F323. doi:10.1136/fn.88.4.F319
  • Grevsen AK, Hviid CVB, Hansen AK, Hvas AM. The role of platelets in premature neonates with intraventricular hemorrhage: a systematic review and meta-analysis. Semin Thromb Hemost. 2020;46(3):366–378. doi:10.1055/s-0039-3402687
  • Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood. 1988;72(5):1651–1657. doi:10.1182/blood.V72.5.1651.1651
  • Barnard DR, Simmons MA, Hathaway WE. Coagulation studies in extremely premature infants. Pediatr Res. 1979;13(12):1330–1335. doi:10.1203/00006450-197912000-00006
  • Nielsen NC. Coagulation and fibrinolysis in diabetic women immediately post partum and in their newborn infants. Influence of caesarean section. Acta Obstet Gynecol Scand. 1969;48(3):392–404. doi:10.3109/00016346909156654
  • Hathaway WE, Mahasandana C, Makowski EL. Cord blood coagulation studies in infants of high-risk pregnant women. Am J Obstet Gynecol. 1975;121(1):51–57. doi:10.1016/0002-9378(75)90974-6
  • Van Deerlin VM, Tollefsen DM. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans. J Biol Chem. 1991;266(30):20223–20231. doi:10.1016/S0021-9258(18)54913-9
  • Mosesson MW. Fibrinogen gamma chain functions. J Menopausal Med. 2003;1(2):231–238. doi:10.1046/j.1538-7836.2003.00063.x
  • MacQuarrie JL, Stafford AR, Yau JW, et al. Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation. Blood. 2011;117(15):4134–4141. doi:10.1182/blood-2010-07-290551
  • Markaki I, Bergstrom S, Tsitsi P, et al. Cerebrospinal fluid levels of Kininogen-1 indicate early cognitive impairment in Parkinson’s disease. Mov Disorders. 2020;35(11):2101–2106. doi:10.1002/mds.28192
  • Ding Q, Yang L, Dinarvand P, Wang X, Rezaie AR. Protein C Thr315Ala variant results in gain of function but manifests as type II deficiency in diagnostic assays. Blood. 2015;125(15):2428–2434. doi:10.1182/blood-2014-12-617274
  • Kovacs KB, Pataki I, Bardos H, et al. Molecular characterization of p.Asp77Gly and the novel p.Ala163Val and p.Ala163Glu mutations causing protein C deficiency. Thromb Res. 2015;135(4):718–726. doi:10.1016/j.thromres.2015.01.011
  • Richani K, Soto E, Romero R, et al. Normal pregnancy is characterized by systemic activation of the complement system. J Mater Fetal Neonatal Med. 2005;17(4):239–245. doi:10.1080/14767050500072722
  • Lappas M. Lower circulating levels of complement split proteins C3a and C4a in maternal plasma of women with gestational diabetes mellitus. Diabetic Med. 2011;28(8):906–911. doi:10.1111/j.1464-5491.2011.03336.x
  • Ramanjaneya M, Butler AE, Alkasem M, et al. Association of complement-related proteins in subjects with and without second trimester gestational diabetes. Front Endocrinol. 2021;12:641361. doi:10.3389/fendo.2021.641361
  • Van de Walle I, Silence K, Budding K, et al. ARGX-117, a therapeutic complement inhibiting antibody targeting C2. J Allergy Clin Immunol. 2021;147(4):1420–1429 e1427. doi:10.1016/j.jaci.2020.08.028
  • Peng M, Li Z, Niu D, Liu X, Dong Z, Li J. Complement factor B/C2 in molluscs regulates agglutination and illuminates evolution of the Bf/C2 family. FASEB J. 2019;33(12):13323–13333. doi:10.1096/fj.201901142RR
  • Barnum SR. C4a: an anaphylatoxin in name only. J Innate Immun. 2015;7(4):333–339. doi:10.1159/000371423
  • Zhao Y, Xu H, Yu W, Xie BD. Complement anaphylatoxin C4a inhibits C5a-induced neointima formation following arterial injury. Mol Med Rep. 2014;10(1):45–52. doi:10.3892/mmr.2014.2176
  • Kishore U, Reid KB. C1q: structure, function, and receptors. Immunopharmacology. 2000;49(1–2):159–170. doi:10.1016/S0162-3109(00)80301-X
  • Fouet G, Bally I, Signor L, et al. Headless C1q: a new molecular tool to decipher its collagen-like functions. FEBS J. 2021;288(6):2030–2041. doi:10.1111/febs.15543